MUKKA30.68

Mukka Proteins Limited

· FMCG & Retail
₹ CrorePeersNARMADAKSEMcap ₹920 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
MUKKA
FY26
NARMADA
FY26
KSE
FY26
Peer
Median
Valuation — at last close
P/E17.63×13.73×13.73× +28%
P/B1.74×0.90×0.90× +94%
EV/EBITDA14.62×12.67×12.67× +15%
Market Cap₹920 Cr₹53.1 Cr₹53.1 Cr +1633%
Growth
Revenue CAGR 3Y16.15%16.15%
Net Income CAGR 3Y80.84%80.84%
Revenue YoY (latest Q)186.73%100.89%100.89% +85%
Net Income YoY (latest Q)1072.69%-26.03%-26.03% +4221%
Profitability
EBITDA Margin7.91%6.35%7.42%6.88% +15%
Net Income Margin3.94%4.92%5.00%4.96% -21%
Return on Common Equity9.85%6.50%24.05%15.28% -36%
Return on Capital Employed17.13%7.87%31.24%19.55% -12%
Return on Assets3.52%5.34%20.25%12.79% -72%
Credit & Quality
Total Debt/Equity1.45×0.17×0.17× +753%
Interest Coverage1.83×5.80×45.02×25.41× -93%
Scale — latest FY
Revenue / Total Income₹1,449 Cr₹78.4 Cr₹1,680 Cr₹879 Cr +65%
Net Income₹57.1 Cr₹3.9 Cr₹84 Cr₹43.9 Cr +30%
Total Assets₹1,621 Cr₹72.3 Cr₹415 Cr₹244 Cr +565%
EPS₹1.74₹1.02₹1.02 +71%
Book Value per Share₹17.63₹15.64₹15.64 +13%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.